Viatris Inc (VTRS)

Jan 14, 2025, 2:03 PM EST - 3 days ago

Viatris Inc. (VTRS) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

Jan 7, 2025, 6:59 AM EST - 10 days ago

Viatris to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 1:46 PM EST - 11 days ago

Viatris: Looking At High Free Cash Flow Yield As Business Stabilizes

Dec 23, 2024, 8:12 AM EST - 25 days ago

US FDA sends warning letter to Viatris over India manufacturing facility

Dec 18, 2024, 6:59 AM EST - 4 weeks ago

Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology

Dec 2, 2024, 8:30 AM EST - 6 weeks ago

Mapi Pharma is Seeking New Depot Product Partnerships

Nov 22, 2024, 5:01 AM EST - 2 months ago

UK watchdog fines Viatris $1.9 mln over rule breach in Theramex probe

Nov 21, 2024, 8:59 AM EST - 2 months ago

Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)

Nov 15, 2024, 3:21 PM EST - 2 months ago

Viatris Inc. (VTRS) UBS Global Healthcare Conference (Transcript)

Nov 8, 2024, 2:36 PM EST - 2 months ago

Bargain Priced Viatris Reports Strong Q3 Earnings Results

Nov 7, 2024, 12:39 PM EST - 2 months ago

Generic Drugmaker Viatris Beats Expectations In Q3, CEO Praises $2 Billion Debt Paydown

Nov 7, 2024, 10:50 AM EST - 2 months ago

Viatris Inc. (VTRS) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 8:57 AM EST - 2 months ago

Xanax maker Viatris beats quarterly estimates on demand for new generic drugs

Nov 7, 2024, 6:59 AM EST - 2 months ago

Viatris Reports Third Quarter Financial Results for 2024

Nov 5, 2024, 6:59 AM EST - 2 months ago

Viatris Announces Third Quarter 2024 Dividend

Oct 29, 2024, 12:00 PM EDT - 2 months ago

Viatris Named to Forbes' World's Top Companies for Women 2024 List

Oct 29, 2024, 9:00 AM EDT - 2 months ago

Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference

Oct 29, 2024, 2:00 AM EDT - 2 months ago

Idorsia announces financial results for the first nine months of 2024

Oct 22, 2024, 3:56 PM EDT - 3 months ago

Viatris Ahead Of Q3 Earnings: No Longer A 'Screaming' Bargain, But Still A Buy

Oct 16, 2024, 4:34 PM EDT - 3 months ago

Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe

LXRX

Oct 9, 2024, 6:59 AM EDT - 3 months ago

Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)

Oct 8, 2024, 11:00 AM EDT - 3 months ago

Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row

Sep 18, 2024, 11:30 AM EDT - 4 months ago

Viatris Announces the Pricing Terms of Maximum Tender Offer

Sep 17, 2024, 8:45 PM EDT - 4 months ago

Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer

Sep 16, 2024, 4:30 PM EDT - 4 months ago

Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024

Sep 10, 2024, 7:00 PM EDT - 4 months ago

Viatris Announces Expiration and Results of Any and All Cash Tender Offers

Sep 10, 2024, 11:40 AM EDT - 4 months ago

Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers

Sep 4, 2024, 3:30 AM EDT - 4 months ago

Viatris Announces Cash Tender Offers for Certain Outstanding Notes

Aug 23, 2024, 6:59 AM EDT - 5 months ago

Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress

Aug 15, 2024, 10:57 AM EDT - 5 months ago

Why Bargain-Priced Viatris Could Deliver Strong Returns

Aug 8, 2024, 1:54 PM EDT - 5 months ago

US Drugmaker Viatris Q2 Earnings Edge Out Analysts Expectation On Strong Demand For Branded And Generic Drugs

Aug 8, 2024, 11:14 AM EDT - 5 months ago

Viatris Inc. (VTRS) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 8:40 AM EDT - 5 months ago

Viagra-maker Viatris beats Q2 estimates on branded and generic drug demand

Aug 8, 2024, 6:59 AM EDT - 5 months ago

Viatris Reports Second Quarter Financial Results for 2024

Aug 6, 2024, 6:59 AM EDT - 5 months ago

Viatris Announces Second Quarter 2024 Dividend

Aug 5, 2024, 4:43 PM EDT - 5 months ago

Novartis, Viatris face new lawsuit over 'HeLa' cell misuse claims

NVS

Jul 26, 2024, 12:00 PM EDT - 6 months ago

Viatris Inc (VTRS:NAS) Company Profile: Analytics, Extensive Financial Metrics, and Benchmark Against Averages and Top Companies Within its Industry

Jul 25, 2024, 1:00 AM EDT - 6 months ago

Idorsia announces financial results for the first half 2024

Jul 3, 2024, 8:30 AM EDT - 7 months ago

Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture

Jul 2, 2024, 8:17 AM EDT - 7 months ago

US DOJ drops Viatris unit Mylan from industry-wide antitrust probe

Jul 2, 2024, 7:30 AM EDT - 7 months ago

U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation

Jun 25, 2024, 11:00 AM EDT - 7 months ago

Viatris Named to TIME's World's Most Sustainable Companies 2024 List

Jun 11, 2024, 6:03 PM EDT - 7 months ago

Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)

Jun 7, 2024, 6:59 AM EDT - 8 months ago

Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024

Jun 6, 2024, 2:12 PM EDT - 8 months ago

Viatris Inc. (VTRS) Presents at Jefferies 2024 Global Healthcare Conference (Transcript)

Jun 4, 2024, 6:59 AM EDT - 8 months ago

Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Jun 3, 2024, 6:59 AM EDT - 8 months ago

Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors

May 31, 2024, 6:59 AM EDT - 8 months ago

Viatris to Participate in the Jeffries Global Healthcare Conference

May 30, 2024, 6:16 PM EDT - 8 months ago

Viatris: Skeptics Proven Right Once Again

May 21, 2024, 6:59 AM EDT - 8 months ago

Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale